Caribou Biosciences Inc. - CRBU Net earnings per share for the last 12 months

Caribou Biosciences, Inc (CRBU) - corporate logo

The market trend on the GURU.Markets platform for the EPS of Caribou Biosciences (CRBU) is 39.00. The business relies on CRISPR gene editing, where growth potential is embedded in patent licensing. The high value of these innovations will provide the company with pricing power. However, FDA pressure regarding method safety and R&D costs create significant financial and legal risks.

cariboubio.com (CRBU): Earnings per share for the last twelve months from 02/11/2024 to 11/18/2026

Financial and market metric breakdowns for Caribou Biosciences (CRBU)

Fundamental company valuation:CRBU Caribou Biosciences, Inc.
Flagship merchandise of Caribou Biosciences, Inc

This indicator measures the dynamics of net earnings per share over a twelve-month period relative to the previous year. Analyzing the rolling annual change in EPS allows for an assessment of business capitalization rates and cost management efficiency. The stability of this metric confirms the issuer's operational resilience amid market volatility. For Caribou Biosciences (CRBU), such an assessment is critical, as it weighs CRISPR development costs against the support of strategic partners.